Pediatric Megaloblastic Anemia Clinical Presentation

  • Author: James L Harper, MD; Chief Editor: Max J Coppes, MD, PhD, MBA   more...
 
Updated: Aug 26, 2011
 

History

Dietary history

A careful dietary history is essential to the diagnosis of megaloblastic anemia. The type and quantity of foods should be documented. In the case of a breastfed infant with megaloblastic anemia, the maternal dietary history should also be obtained.

Document dietary faddism or family-induced dietary restriction. Folate deficiency may result if the child's only source of dietary folic acid is goat's milk.

Children with one nutrient deficiency are at increased risk for other deficiencies; thus, search the history for evidence of other nutrient deficiencies.

Dietary vitamin B-12 deficiency in infants is extremely rare, but may occur in breastfed infants whose mothers are B-12 deficient. Obtain a careful history of the mother's diet. Include the mother's current diet, her diet while pregnant, and her diet before pregnancy. Vitamin B-12 deficiency is most common in women who have no meat in their diet.

GI disease

Carefully document the presence or absence of malabsorption syndromes, sprue, and preexisting conditions such as intestinal blind-loop syndrome or bowel resection. Evaluate for other acquired GI disorders, such as fish tapeworm infestation by Diphyllobothrium latum. Evaluate for Crohn disease and other causes of chronic inflammation of the ileum as potential causes of B-12 malabsorption. Carefully monitor for megaloblastic anemia due to impaired absorption of B-12 or folic acid following surgery involving the stomach, jejunum, or ileum.

Bone or joint pain, bruising, or bleeding

Bone and joint pain suggest that the child may have leukemia or another malignancy, with marrow replacement as the cause of pancytopenia. Bleeding and bruising are often observed in association with vitamin B-12 deficiency caused by thrombocytopenia, but these symptoms should also raise suspicion of leukemia or other marrow replacement disorders.

Medication

A history of sulfa exposure or use of antifolate antimetabolite chemotherapeutic agents, such as methotrexate, trimetrexate, or azathioprine, should be considered. Also consider the use of other antifolate drugs or drugs that affect the absorption of either folic acid or vitamin B-12. For example, certain anticonvulsants (eg, phenytoin, primidone) impair folate absorption.

Family history

Congenital absence or deficiency of carrier proteins is a common cause of vitamin B-12 deficiency. These deficiencies occur in families. Obtaining an extended family history is usually necessary to detect other affected family members. These conditions often manifest during infancy and early childhood and are rare but important causes of megaloblastic anemia because myelopathy and developmental delays occur without treatment.

Evaluate for Imerslund-Grasbeck syndrome of proteinuria and excretion of cobalamin and intrinsic factor (IF).

Next

Physical Examination

The physical examination is largely directed by the findings of the history. Common findings include glossitis, stomatitis, hyperpigmentation, and weight loss.

Look for physical evidence of anemia, thrombocytopenia, and neutropenia. Pancytopenia can be observed in megaloblastic anemia, but it should raise the suspicion of a possible malignancy.

Evaluate for lymphadenopathy, hepatosplenomegaly, and abdominal or retroperitoneal masses as evidence of a malignancy.

Carefully document the neurologic status of a child with megaloblastic anemia. Document altered mental or neurologic status. Vibratory sensation in the extremities is frequently affected in vitamin B-12 deficiency.[7] These changes may reflect neurotoxicity from deficient B-12 levels. Once documented, these symptoms can be monitored to determine the degree of resolution once the child is B-12 replete.

Previous
 
 
Contributor Information and Disclosures
Author

James L Harper, MD  Associate Professor, Department of Pediatrics, Division of Hematology/Oncology and Bone Marrow Transplantation, Associate Chairman for Education, Department of Pediatrics, University of Nebraska Medical Center; Assistant Clinical Professor, Department of Pediatrics, Creighton University School of Medicine; Director, Continuing Medical Education, Children's Memorial Hospital; Pediatric Director, Nebraska Regional Hemophilia Treatment Center

James L Harper, MD is a member of the following medical societies: American Academy of Pediatrics, American Association for Cancer Research, American Federation for Clinical Research, American Society of Hematology, American Society of Pediatric Hematology/Oncology, Council on Medical Student Education in Pediatrics, and Hemophilia and Thrombosis Research Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Sharada A Sarnaik, MBBS  Professor of Pediatrics, Wayne State University School of Medicine; Director, Sickle Cell Center, Attending Hematologist/Oncologist, Children's Hospital of Michigan

Sharada A Sarnaik, MBBS is a member of the following medical societies: American Association of Blood Banks, American Association of University Professors, American Society of Hematology, American Society of Pediatric Hematology/Oncology, New York Academy of Sciences, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Steven K Bergstrom, MD  Department of Pediatrics, Division of Hematology-Oncology, Kaiser Permanente Medical Center of Oakland

Steven K Bergstrom, MD is a member of the following medical societies: Alpha Omega Alpha, American Society of Clinical Oncology, American Society of Hematology, American Society of Pediatric Hematology/Oncology, Children's Oncology Group, and International Society for Experimental Hematology

Disclosure: Nothing to disclose.

Chief Editor

Max J Coppes, MD, PhD, MBA  Senior Vice President, Center for Cancer and Blood Disorders, Children's National Medical Center; Professor of Medicine, Oncology, and Pediatrics, Georgetown University School of Medicine; Clinical Professor of Pediatrics, George Washington University School of Medicine and Health Sciences

Max J Coppes, MD, PhD, MBA is a member of the following medical societies: American Association for Cancer Research, American Society of Pediatric Hematology/Oncology, and Society for Pediatric Research

Disclosure: Nothing to disclose.

References
  1. Lorber A, Gazit AZ, Khoury A, Schwartz Y, Mandel H. Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome. Pediatr Cardiol. Sep-Oct 2003;24(5):476-81. [Medline].

  2. Olsen BS, Hahnemann JM, Schwartz M, Østergaard E. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood. Pediatr Diabetes. Aug 2007;8(4):239-41. [Medline].

  3. Whitehead VM. Acquired and inherited disorders of cobalamin and folate in children. Br J Haematol. Jul 2006;134(2):125-36. [Medline].

  4. Korenke GC, Hunneman DH, Eber S, Hanefeld F. Severe encephalopathy with epilepsy in an infant caused by subclinical maternal pernicious anaemia: case report and review of the literature. Eur J Pediatr. Apr 2004;163(4-5):196-201. [Medline].

  5. Molloy AM, Kirke PN, Brody LC, Scott JM, Mills JL. Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development. Food Nutr Bull. Jun 2008;29(2 Suppl):S101-11; discussion S112-5. [Medline].

  6. Erkurt MA, Aydogdu I, Dikilitas M, Kuku I, Kaya E, Bayraktar N, et al. Effects of cyanocobalamin on immunity in patients with pernicious anemia. Med Princ Pract. 2008;17(2):131-5. [Medline].

  7. Dror DK, Allen LH. Effect of vitamin B12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms. Nutr Rev. May 2008;66(5):250-5. [Medline].

  8. Dugué B, Ismail E, Sequeira F, Thakkar J, Gräsbeck R. Urinary excretion of intrinsic factor and the receptor for its cobalamin complex in Gräsbeck-Imerslund patients: the disease may have subsets. J Pediatr Gastroenterol Nutr. Aug 1999;29(2):227-30. [Medline].

Previous
Next
 
Bone marrow aspirate from a patient with untreated pernicious anemia. Megaloblastic maturation of erythroid precursors is shown. Two megaloblasts occupy the center of the slide with a megaloblastic normoblast above. Photo courtesy of Marcel E Conrad, MD.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.